Breaking News Instant updates and real-time market news.

KURA

Kura Oncology

$33.66 /

-0.45 (-1.32%)

17:37
12/02/20
12/02
17:37
12/02/20
17:37

Kura Oncology initiated with a Buy at Stifel

Stifel analyst Konstantinos Aprilakis initiated coverage of Kura Oncology with a Buy rating and $45 price target, citing the company's "two pillars of near-term value," KO-539, a menin inhibitor for MLLr- and NPM1m-AML, and tipifarnib, a farnesyltransferase inhibitor for HRAS-driven head and neck squamous cell carcinoma.

  • 05

    Dec

  • 06

    May

KURA Kura Oncology
$33.66 /

-0.45 (-1.32%)

11/05/20 Piper Sandler
Piper downgrades Kura Oncology to Neutral with KO-539 expectations priced in
11/05/20 Piper Sandler
Kura Oncology downgraded to Neutral from Overweight at Piper Sandler
10/26/20 JMP Securities
Kura Oncology price target raised to $33 from $22 at JMP Securities
10/12/20 H.C. Wainwright
Kura Oncology price target raised to $40 from $22 at H.C. Wainwright

TODAY'S FREE FLY STORIES

Hot Stocks
Plug Power identifies 'material weakness' in internal controls over reporting » 07:18
05/14/21
05/14
07:18
05/14/21
07:18
PLUG

Plug Power

$21.96 /

-0.27 (-1.21%)

As previously announced,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLUG Plug Power
$21.96 /

-0.27 (-1.21%)

PLUG Plug Power
$21.96 /

-0.27 (-1.21%)

04/19/21 Evercore ISI
Plug Power initiated with an Outperform at Evercore ISI
04/19/21 Wells Fargo
Plug Power initiated with an Equal Weight at Wells Fargo
04/12/21 Morgan Stanley
Plug Power resumed at Equal Weight from Overweight at Morgan Stanley
04/12/21 Morgan Stanley
Plug Power downgraded to Equal Weight from Overweight at Morgan Stanley
PLUG Plug Power
$21.96 /

-0.27 (-1.21%)

  • 27
    Jan
  • 17
    Nov
  • 12
    Aug
PLUG Plug Power
$21.96 /

-0.27 (-1.21%)

PLUG Plug Power
$21.96 /

-0.27 (-1.21%)

PLUG Plug Power
$21.96 /

-0.27 (-1.21%)

Hot Stocks
Dyne Therapeutics present preclinical data on myotonic dystrophy type 1 program » 07:18
05/14/21
05/14
07:18
05/14/21
07:18
DYN

Dyne Therapeutics

$17.01 /

-0.26 (-1.51%)

Dyne Therapeutics is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DYN Dyne Therapeutics
$17.01 /

-0.26 (-1.51%)

DYN Dyne Therapeutics
$17.01 /

-0.26 (-1.51%)

03/05/21 Stifel
Dyne Therapeutics weakness a buying opportunity, says Stifel
02/09/21
Dyne Therapeutics initiated with a Buy at JonesTrading
01/07/21 Piper Sandler
Dyne Therapeutics potential beneficiary of Sarepta's SRP-9001 miss, says Piper
10/12/20 Jefferies
Dyne Therapeutics initiated with a Buy at Jefferies
DYN Dyne Therapeutics
$17.01 /

-0.26 (-1.51%)

  • 21
    Jan
  • 17
    Sep
DYN Dyne Therapeutics
$17.01 /

-0.26 (-1.51%)

DYN Dyne Therapeutics
$17.01 /

-0.26 (-1.51%)

Upgrade
DoorDash upgraded to Buy from Hold at Truist » 07:17
05/14/21
05/14
07:17
05/14/21
07:17
DASH

DoorDash

$116.22 /

+3.24 (+2.87%)

Truist analyst Youssef…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DASH DoorDash
$116.22 /

+3.24 (+2.87%)

DASH DoorDash
$116.22 /

+3.24 (+2.87%)

06:56 Today Truist
DoorDash upgraded to Buy from Hold at Truist
06:41 Today Mizuho
DoorDash price target lowered to $155 from $170 at Mizuho
05/05/21 Cowen
Department of Labor comments incrementally encouraging for Uber/Lyft, says Cowen
04/26/21 Needham
DoorDash initiated with a Buy at Needham
DASH DoorDash
$116.22 /

+3.24 (+2.87%)

  • 09
    Dec
DASH DoorDash
$116.22 /

+3.24 (+2.87%)

DASH DoorDash
$116.22 /

+3.24 (+2.87%)

DASH DoorDash
$116.22 /

+3.24 (+2.87%)

Recommendations
Yeti price target raised to $105 from $88 at BofA » 07:17
05/14/21
05/14
07:17
05/14/21
07:17
YETI

Yeti

$85.73 /

+4.22 (+5.18%)

BofA analyst Robert Ohmes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
YETI Yeti
$85.73 /

+4.22 (+5.18%)

YETI Yeti
$85.73 /

+4.22 (+5.18%)

07:04 Today Credit Suisse
Yeti price target raised to $105 from $85 at Credit Suisse
06:34 Today KeyBanc
Yeti price target raised to $94 from $80 at KeyBanc
06:17 Today Citi
Yeti price target raised to $106 from $101 at Citi
05/12/21 BTIG
Yeti price target raised to $100 from $90 at BTIG
YETI Yeti
$85.73 /

+4.22 (+5.18%)

  • 28
    May
YETI Yeti
$85.73 /

+4.22 (+5.18%)

YETI Yeti
$85.73 /

+4.22 (+5.18%)

YETI Yeti
$85.73 /

+4.22 (+5.18%)

Earnings
Onex reports Q1 segment net EPS $5.12 » 07:16
05/14/21
05/14
07:16
05/14/21
07:16
ONEXF

Onex

$67.99 /

-0.02 (-0.03%)

Onex reported Q1 total…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ONEXF Onex
$67.99 /

-0.02 (-0.03%)

ONEXF Onex
$67.99 /

-0.02 (-0.03%)

04/26/21 CIBC
Onex price target raised to C$94 from C$92 at CIBC
03/01/21 RBC Capital
Onex price target raised to C$103 from C$91 at RBC Capital
03/01/21 Stifel
Onex price target raised to C$100 from C$92.50 at Stifel
03/01/21 Canaccord
Onex price target raised to C$91 from C$88 at Canaccord
ONEXF Onex
$67.99 /

-0.02 (-0.03%)

ONEXF Onex
$67.99 /

-0.02 (-0.03%)

Syndicate
Alpine Immune Sciences files $150M mixed securities shelf  07:16
05/14/21
05/14
07:16
05/14/21
07:16
ALPN

Alpine Immune Sciences

$11.52 /

-0.05 (-0.43%)

 
ShowHide Related Items >><<
ALPN Alpine Immune Sciences
$11.52 /

-0.05 (-0.43%)

ALPN Alpine Immune Sciences
$11.52 /

-0.05 (-0.43%)

12/21/20 H.C. Wainwright
Alpine Immune Sciences initiated with a Buy at H.C. Wainwright
08/26/20 Cowen
Alpine Immune Sciences initiated with an Outperform at Cowen
08/11/20 Piper Sandler
Alpine Immune Sciences price target lowered to $18 from $21 at Piper Sandler
06/19/20 Wedbush
Alpine Immune price target raised to $22 from $10 at Wedbush
ALPN Alpine Immune Sciences
$11.52 /

-0.05 (-0.43%)

ALPN Alpine Immune Sciences
$11.52 /

-0.05 (-0.43%)

Syndicate
Duos Technologies Group files to sell 818.2K shares of common stock for holders  07:15
05/14/21
05/14
07:15
05/14/21
07:15
DUOT

Duos Technologies Group

$8.80 /

+0.02 (+0.23%)

 
ShowHide Related Items >><<
    Recommendations
    PhaseBio remains 'significantly undervalued,' says William Blair » 07:14
    05/14/21
    05/14
    07:14
    05/14/21
    07:14
    PHAS

    PhaseBio

    $2.81 /

    -0.11 (-3.77%)

    William Blair analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    PHAS PhaseBio
    $2.81 /

    -0.11 (-3.77%)

    PHAS PhaseBio
    $2.81 /

    -0.11 (-3.77%)

    03/16/21 Needham
    PhaseBio price target raised to Street high $19 at Needham
    08/25/20 Citi
    PhaseBio price target lowered to $10 from $12 at Citi
    07/10/20 Stifel
    PhaseBio transferred with Buy rating, $11 target at Stifel
    05/29/20 Citi
    PhaseBio price target raised to $12 from $11 at Citi
    PHAS PhaseBio
    $2.81 /

    -0.11 (-3.77%)

    • 18
      Mar
    PHAS PhaseBio
    $2.81 /

    -0.11 (-3.77%)

    Hot Stocks
    Sandy Spring Bancorp announces executive, senior leadership appointments » 07:13
    05/14/21
    05/14
    07:13
    05/14/21
    07:13
    SASR

    Sandy Spring Bancorp

    $47.31 /

    +1.85 (+4.07%)

    Sandy Spring Bank…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    SASR Sandy Spring Bancorp
    $47.31 /

    +1.85 (+4.07%)

    SASR Sandy Spring Bancorp
    $47.31 /

    +1.85 (+4.07%)

    01/25/21 Piper Sandler
    Sandy Spring Bancorp upgraded to Overweight from Neutral at Piper Sandler
    12/09/20 Gabelli
    Sandy Spring Bancorp downgraded to Hold from Buy at Gabelli
    12/09/20 Gabelli
    Sandy Spring Bancorp downgraded to Hold from Buy at Gabelli
    08/03/20 Piper Sandler
    Sandy Spring Bancorp resumed with a Neutral at Piper Sandler
    SASR Sandy Spring Bancorp
    $47.31 /

    +1.85 (+4.07%)

    Recommendations
    Disney price target lowered to $215 from $225 at Goldman Sachs » 07:13
    05/14/21
    05/14
    07:13
    05/14/21
    07:13
    DIS

    Disney

    $178.11 /

    +0.26 (+0.15%)

    Goldman Sachs analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    DIS Disney
    $178.11 /

    +0.26 (+0.15%)

    DIS Disney
    $178.11 /

    +0.26 (+0.15%)

    06:57 Today Citi
    Disney shares to trade down on moderated sub outlook, says Citi
    05/12/21 Morgan Stanley
    Disney price target raised to $210 from $200 at Morgan Stanley
    05/10/21 Evercore ISI
    American Campus upgraded to Outperform at Evercore ISI on faster Disney ramp
    05/03/21 BofA
    BofA adds Disney and Avalara, removes Comcast and Netflix from U.S. 1 List
    DIS Disney
    $178.11 /

    +0.26 (+0.15%)

    DIS Disney
    $178.11 /

    +0.26 (+0.15%)

    DIS Disney
    $178.11 /

    +0.26 (+0.15%)

    DIS Disney
    $178.11 /

    +0.26 (+0.15%)

    Hot Stocks
    Flyht Aerospace announces amendment to grant of incentive stock options » 07:13
    05/14/21
    05/14
    07:13
    05/14/21
    07:13
    FLYLF

    Flyht Aerospace

    /

    +

    FLYHT Aerospace Solutions…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    FLYLF Flyht Aerospace
    /

    +

    FLYLF Flyht Aerospace
    /

    +

    12/02/20 Lake Street
    Flyht Aerospace initiated with a Buy at Lake Street
    Upgrade
    Kimberly-Clark upgraded to Equal Weight from Underweight at Wells Fargo » 07:13
    05/14/21
    05/14
    07:13
    05/14/21
    07:13
    KMB

    Kimberly-Clark

    $133.78 /

    +0.78 (+0.59%)

    Wells Fargo analyst Chris…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    KMB Kimberly-Clark
    $133.78 /

    +0.78 (+0.59%)

    KMB Kimberly-Clark
    $133.78 /

    +0.78 (+0.59%)

    06:11 Today Wells Fargo
    Kimberly-Clark upgraded to Equal Weight from Underweight at Wells Fargo
    04/26/21 RBC Capital
    Kimberly-Clark price target lowered to $137 from $147 at RBC Capital
    04/26/21 Jefferies
    Kimberly-Clark price target lowered to $150 from $160 at Jefferies
    04/26/21 Deutsche Bank
    Kimberly-Clark price target lowered to $137 from $145 at Deutsche Bank
    KMB Kimberly-Clark
    $133.78 /

    +0.78 (+0.59%)

    KMB Kimberly-Clark
    $133.78 /

    +0.78 (+0.59%)

    Earnings
    Great Elm Group reports Q3 EPS (11c) vs. (46c) last year » 07:12
    05/14/21
    05/14
    07:12
    05/14/21
    07:12
    GEG

    Great Elm Group

    $2.31 /

    + (+0.00%)

    Reports Q3 revenue $15.1M…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    Upgrade
    Airbnb upgraded to Overweight from Equal Weight at Wells Fargo » 07:11
    05/14/21
    05/14
    07:11
    05/14/21
    07:11
    ABNB

    Airbnb

    $135.95 /

    -4.22 (-3.01%)

    Wells Fargo analyst Brian…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    ABNB Airbnb
    $135.95 /

    -4.22 (-3.01%)

    ABNB Airbnb
    $135.95 /

    -4.22 (-3.01%)

    06:58 Today Wells Fargo
    Airbnb upgraded to Overweight from Equal Weight at Wells Fargo
    06:47 Today Baird
    Airbnb price target lowered to $200 from $210 at Baird
    06:40 Today Mizuho
    Airbnb price target lowered to $165 from $176 at Mizuho
    06:34 Today Barclays
    Airbnb price target lowered to $140 from $180 at Barclays
    ABNB Airbnb
    $135.95 /

    -4.22 (-3.01%)

    • 10
      Dec
    ABNB Airbnb
    $135.95 /

    -4.22 (-3.01%)

    ABNB Airbnb
    $135.95 /

    -4.22 (-3.01%)

    ABNB Airbnb
    $135.95 /

    -4.22 (-3.01%)

    Hot Stocks
    Flora Growth expands into U.K., Central American markets » 07:10
    05/14/21
    05/14
    07:10
    05/14/21
    07:10
    FLGC

    Flora Growth

    $3.80 /

    -0.86 (-18.45%)

    Flora Growth announced it…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    • 11
      May
    Earnings
    Telesat reports Q1 revenue $190.49M vs. $208.67M last year » 07:09
    05/14/21
    05/14
    07:09
    05/14/21
    07:09
    LORL

    Loral Space & Communications

    $36.15 /

    +0.05 (+0.14%)

    Reports net income $42M…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    LORL Loral Space & Communications
    $36.15 /

    +0.05 (+0.14%)

    LORL Loral Space & Communications
    $36.15 /

    +0.05 (+0.14%)

    02/09/21 LightShed Partners
    Loral Space & Communications initiated with a Buy at LightShed Partners
    LORL Loral Space & Communications
    $36.15 /

    +0.05 (+0.14%)

    Recommendations
    PubMatic price target lowered to $50 from $55 at Oppenheimer » 07:09
    05/14/21
    05/14
    07:09
    05/14/21
    07:09
    PUBM

    PubMatic

    $34.30 /

    -3.53 (-9.33%)

    Oppenheimer analyst Brian…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    PUBM PubMatic
    $34.30 /

    -3.53 (-9.33%)

    06:11 Today RBC Capital
    PubMatic assumed with an Outperform at RBC Capital
    04/05/21 Evercore ISI
    PubMatic initiated with an In Line at Evercore ISI
    03/15/21 Cannonball Research
    PubMatic initiated with a Neutral at Cannonball Research
    03/08/21 KeyBanc
    Trade Desk upgraded to Overweight from Sector Weight at KeyBanc
    PUBM PubMatic
    $34.30 /

    -3.53 (-9.33%)

    • 09
      Dec
    PUBM PubMatic
    $34.30 /

    -3.53 (-9.33%)

    PUBM PubMatic
    $34.30 /

    -3.53 (-9.33%)

    Upgrade
    Vivint Smart Home upgraded to Buy from Neutral at Goldman Sachs » 07:09
    05/14/21
    05/14
    07:09
    05/14/21
    07:09
    VVNT

    Vivint Smart Home

    $11.75 /

    +0.6 (+5.38%)

    Goldman Sachs analyst Rod…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    VVNT Vivint Smart Home
    $11.75 /

    +0.6 (+5.38%)

    VVNT Vivint Smart Home
    $11.75 /

    +0.6 (+5.38%)

    03/11/21 Deutsche Bank
    Vivint upgraded to Buy on long-term opportunities at Deutsche Bank
    03/11/21 Deutsche Bank
    Vivint Smart Home upgraded to Buy from Hold at Deutsche Bank
    02/25/21 Deutsche Bank
    Vivint Smart Home price target lowered to $21 from $24 at Deutsche Bank
    01/15/21 Deutsche Bank
    Vivint Smart Home downgraded to Hold on valuation at Deutsche Bank
    VVNT Vivint Smart Home
    $11.75 /

    +0.6 (+5.38%)

    VVNT Vivint Smart Home
    $11.75 /

    +0.6 (+5.38%)

    Earnings
    Bio-Path reports Q1 EPS (43c), two estimates (45c) » 07:08
    05/14/21
    05/14
    07:08
    05/14/21
    07:08
    BPTH

    Bio-Path

    $5.16 /

    -0.23 (-4.27%)

    As of March 31, 2021, the…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    BPTH Bio-Path
    $5.16 /

    -0.23 (-4.27%)

    BPTH Bio-Path
    $5.16 /

    -0.23 (-4.27%)

    04/06/21 H.C. Wainwright
    Bio-Path price target raised to $12 from $10 at H.C. Wainwright
    04/05/21 Roth Capital
    Bio-Path triple regimen data 'highly favorable,' says Roth Capital
    03/11/21 Roth Capital
    Bio-Path Holdings initiated with a Buy at Roth Capital
    11/16/20 H.C. Wainwright
    Bio-Path Holdings price target lowered to $10 from $12 at H.C. Wainwright
    BPTH Bio-Path
    $5.16 /

    -0.23 (-4.27%)

    • 16
      Feb
    Recommendations
    Chicken Soup for the Soul price target raised to $52 at Alliance Global » 07:06
    05/14/21
    05/14
    07:06
    05/14/21
    07:06
    CSSE

    Chicken Soup for the Soul

    $32.89 /

    -1.855 (-5.34%)

    Alliance Global Partners…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    CSSE Chicken Soup for the Soul
    $32.89 /

    -1.855 (-5.34%)

    CSSE Chicken Soup for the Soul
    $32.89 /

    -1.855 (-5.34%)

    05/13/21 Canaccord
    Canaccord starts Chicken Soup for the Soul with Buy, $50 price target
    05/13/21 Canaccord
    Chicken Soup for the Soul initiated with a Buy at Canaccord
    04/12/21 Craig-Hallum
    Chicken Soup for the Soul price target raised to $48 from $35 at Craig-Hallum
    04/12/21 Northland
    Chicken Soup for the Soul price target raised to $40 from $30 at Northland
    Hot Stocks
    Regenxbio reports interim data from Phase I/II trial of RGX-12 » 07:06
    05/14/21
    05/14
    07:06
    05/14/21
    07:06
    RGNX

    Regenxbio

    $35.35 /

    +0.51 (+1.46%)

    REGENXBIO announced a…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    RGNX Regenxbio
    $35.35 /

    +0.51 (+1.46%)

    RGNX Regenxbio
    $35.35 /

    +0.51 (+1.46%)

    04/29/21 Chardan
    Chardan downgrades Adverum after serious adverse reaction disclosure
    04/05/21 Morgan Stanley
    Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
    02/09/21 Morgan Stanley
    Sarepta denied motion to dismiss 'Wilson Wolf' case, says Morgan Stanley
    01/20/21 RBC Capital
    Regenxbio price target raised to $50 from $42 at RBC Capital
    RGNX Regenxbio
    $35.35 /

    +0.51 (+1.46%)

    • 08
      Jan
    RGNX Regenxbio
    $35.35 /

    +0.51 (+1.46%)

    Earnings
    Forma Therapeutics reports Q1 EPS (76c), consensus (76c) » 07:06
    05/14/21
    05/14
    07:06
    05/14/21
    07:06
    FMTX

    Forma Therapeutics

    $24.93 /

    -1.18 (-4.52%)

    Cash, cash equivalents…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    FMTX Forma Therapeutics
    $24.93 /

    -1.18 (-4.52%)

    FMTX Forma Therapeutics
    $24.93 /

    -1.18 (-4.52%)

    03/31/21 H.C. Wainwright
    Forma Therapeutics price target raised to $55 from $53 at H.C. Wainwright
    03/30/21 Piper Sandler
    Agios should rally on Forma Therapeutics data, says Piper Sandler
    02/17/21
    Fly Intel: Top five analyst initiations
    02/17/21 Oppenheimer
    Forma Therapeutics initiated with an Outperform at Oppenheimer
    FMTX Forma Therapeutics
    $24.93 /

    -1.18 (-4.52%)

    • 11
      Dec
    • 19
      Jun
    FMTX Forma Therapeutics
    $24.93 /

    -1.18 (-4.52%)

    Earnings
    Gencor Industries reports Q2 EPS 16c vs. (4c) last year » 07:06
    05/14/21
    05/14
    07:06
    05/14/21
    07:06
    GENC

    Gencor Industries

    $11.43 /

    +0.2 (+1.78%)

    Reports Q2 net revenue…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    GENC Gencor Industries
    $11.43 /

    +0.2 (+1.78%)

    Upgrade
    UDG Healthcare upgraded to Hold at Jefferies after all-cash offer from Nenelite » 07:06
    05/14/21
    05/14
    07:06
    05/14/21
    07:06
    UDHCF

    UDG Healthcare

    $11.63 /

    + (+0.00%)

    As previously reported,…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    UDHCF UDG Healthcare
    $11.63 /

    + (+0.00%)

    05/13/21 Jefferies
    UDG Healthcare upgraded to Hold from Underperform at Jefferies
    05/13/21 Berenberg
    UDG Healthcare downgraded to Hold from Buy at Berenberg
    05/06/21 Barclays
    UDG Healthcare price target raised to 975 GBp from 920 GBp at Barclays
    11/11/20 RBC Capital
    UDG Healthcare upgraded to Outperform from Sector Perform at RBC Capital
    Earnings
    Iterum Therapeutics reports Q1 adjusted EPS (5c), consensus (7c) » 07:05
    05/14/21
    05/14
    07:05
    05/14/21
    07:05
    ITRM

    Iterum Therapeutics

    /

    +

    As of March 31, 2021,…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    ITRM Iterum Therapeutics
    /

    +

    ITRM Iterum Therapeutics
    /

    +

    03/15/21 H.C. Wainwright
    Iterum Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
    12/24/20 H.C. Wainwright
    Iterum CSO resignation 'somewhat troubling,' says H.C. Wainwright
    06/16/20 H.C. Wainwright
    Iterum Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
    06/02/20 RBC Capital
    Iterum Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
    ITRM Iterum Therapeutics
    /

    +

    ITRM Iterum Therapeutics
    /

    +

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.